Management of Parenteral Nutrition in Acutely Ill Patients with Hyperglycemia

Nutrition in Clinical Practice

Volumn 19, Issue 2, 2004, Pages 120-128

  McMahon, M Molly ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ADRENERGIC RECEPTOR STIMULATING AGENT; ASPART; CORTICOSTEROID; GLARGINE; GLUCAGON; GLUCOSE; GLUTOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LENTE; LIPID EMULSION; MIGLITOL; ORAL ANTIDIABETIC AGENT; PROPOFOL; UNCLASSIFIED DRUG;

ACUTE DISEASE; CALORIC INTAKE; CLINICAL TRIAL; CRITICAL ILLNESS; FLUID BALANCE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNE RESPONSE; INFLAMMATION; INSULIN INFUSION; META ANALYSIS; NUTRITIONAL REQUIREMENT; OVERNUTRITION; PARENTERAL NUTRITION; PATIENT MONITORING; REVIEW; RISK BENEFIT ANALYSIS;

EID: 1642423467     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426504019002120     Document Type: Review

References (42)

1. Umpierrez GE, Isaacs SD, Bazargan N, Xiangdong Y, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20: 1183-1197.
3. Shamoon M, Hendler R, Sherwin R. Synergistic interactions among anti-insulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab. 1981;52:1235-1241.
4. Shamoon M. Hendler R, Sherwin R. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetes. Diabetes. 1980;29:284-201.
5. Bistrian BR. Hyperglycemia and infection: which is the chicken and which is the egg? JPEN. 2001;25:180-181.
6. Hostetter M. Perspectives in diabetes: handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990;39:271-275.
7. Gustafson KS, Vercellotti GM, Bendel CM, Hostetter MK. Molecular mimicry in Candida albicans: role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest. 1991;87:1896-1902.
8. Hostetter M. The third component of complement: new functions for an old friend. J Lab Clin Med. 1993;122:491-496.
9. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107-124.
10. McMahon M, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. In: Eliopoulos GM, ed. Infectious Disease Clinics of North America. Philadelphia: Saunders; 1995:1-9.
11. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
12. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
13. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN. 1998;22:77-81.
14. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
15. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607-612.
16. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition (TPN) in surgical patients. N Engl J Med. 1993;325:525-532.
17. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg. 1992;216: 172-183.
18. Kudsk KA, Laulederkind A, Hanna MK. Most infectious complications in parenterally fed trauma patients are not due to elevated blood glucose levels. JPEN. 2001;25:174-179.
19. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341:785-792.
20. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362.
21. Furnary AP, Guangqiang G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
22. Malmberg K, for the DIGAMI Study Group. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
23. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
24. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effects of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082-1088.
25. Von Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assesses quantitatively by dynamic positron emission tomography. Circulation. 1993;88:395-404.
26. Oliver MF, Kurien VA, Greenwood TW. Relation between serum free fatty acids and arrhythmias and death after myocardial infarction. Lancet. 1968;1:710-715.
27. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229:11-18.
28. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the surgical intensive care unit: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
29. McMahon M, Rizza RA. Nutritional support in hospitalized patients with diabetes mellitus. Mayo Clin Proc. 1996;71:587-594.
30. Montori VM, Bistrian BR, McMahon M. Hyperglycemia in acutely ill patients. JAMA. 2002;288:2167-2169.
31. A.S.P.E.N. Board of Directors. Clinical pathways and algorithms for delivery of parenteral and enteral nutrition support in adults. Silver Spring, Maryland: A.S.P.E.N.; 1998.
32. Hurley D, Neven A, McMahon M. Diabetes Mellitus. In: Gottschlich MM, ed. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Dubuque, Iowa: Kendall/Hunt Publishing Company; 2001:663-675.
33. Camilleri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord. 2002;2:47-56.
34. Stacher G. Diabetes mellitus and the stomach. Diabetologia. 2001;44:1080-1093.
35. Hebbard GS, Sun WM, Dent J, Horowitz M. Hyperglycemia affects proximal gastric motor and sensory function in normal subjects. Eur J Gastroenterol Hepatol. 1996;8:211-217.
36. McMahon MM, Farnell MB, Murray MJ. Nutritional support of critically ill patients. Mayo Clin Proc. 1993;68:911-920.
37. Hunter DC, Jaksic T, Lewis D, Benotti PN, Blackburn GL, Bistrian BR. Resting energy expenditure in the critically ill: estimations versus measurement. Br J Surg. 1988;78:875-878.
38. Paauw JD, McCamish MA, Dean RE, Ouelette TR. Assessment of caloric needs in stressed patients. J Am Coll Nutr. 1984;3:51-59.
39. Mann S, Westenskow DR, Houtchens BA. Measured and predicted caloric expenditure in the acutely ill. Crit Care Med. 1985;13:173-177.
40. Malmberg KA, Efendic S, Ryden LE. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction: a report from the multicenter trial: DIGAMI. Diabetes Care. 1994; 17:1007-1014.
41. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-799.
42. Carpentier YA. Intravascular metabolism of fat emulsions. Clin Nutr. 1989;8:115-125.